NMLIC
PTLA

Northwestern Mutual Life Insurance Company’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Northwestern Mutual Life Insurance Company’s Portfolio PTLA Stock Details PTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-16,450
Closed -$426K – 11
2014
Q1 		$426K Buy
+16,450
New +$439K 0.95% 9

Other funds holding PTLA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Northwestern Mutual Life Insurance Company's PTLA Position: Q2 2014 in Review

Northwestern Mutual Life Insurance Company sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q2 2014, closing a stake of 16,450 shares — an estimated $426K sold.

Northwestern Mutual Life Insurance Company first reported a position in PTLA in Q1 2014 and held it in 1 quarter. The position peaked at $426K in Q1 2014. 110 funds tracked by Wall St. Rank hold PTLA as of Q2 2014.

  • Northwestern Mutual Life Insurance Company reported no remaining Portola Pharmaceuticals, Inc. position as of Q2 2014 after selling out during the quarter.
  • Northwestern Mutual Life Insurance Company sold 16,450 Portola Pharmaceuticals, Inc. shares in Q2 2014, an estimated $426K.
  • Northwestern Mutual Life Insurance Company first reported a position in Portola Pharmaceuticals, Inc. in Q1 2014 and held it in 1 quarter.
  • Northwestern Mutual Life Insurance Company's Portola Pharmaceuticals, Inc. position peaked at $426K in Q1 2014.
  • 110 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q2 2014.

Based on Northwestern Mutual Life Insurance Company's 13F filing for Q2 2014, filed 5 Aug 2014.